Mannkind (MNKD) Receivables - Net (2014 - 2026)
Mannkind's (MNKD) quarterly Receivables - Net came in at $28.1 million in Q1 2026, down 2.64% year-on-year from $28.9 million in Q1 2025, and down 26.66% on a QoQ basis from $38.4 million in Q4 2025.
Mannkind (MNKD) Receivables - Net (2014 - 2026) Analysis & Trends
Mannkind (MNKD) has 13 years of Receivables - Net data on file, last reported at $28.1 million in Q1 2026.
- On a quarterly basis, Receivables - Net fell 2.64% year-over-year to $28.1 million in Q1 2026; TTM through Mar 2026 was $28.1 million, a 2.64% decrease from a year earlier, with the FY2025 full-year figure at $38.4 million, up 225.03% from the prior year.
- Receivables - Net for Q1 2026 stood at $28.1 million, down from $38.4 million in the prior quarter.
- Over the last five years, Receivables - Net for MNKD reached as high as $38.4 million in Q4 2025 and fell as low as $200000.0 in Q1 2023.
- Historically, Receivables - Net has averaged $20.2 million across 5 years, with a median of $19.9 million in 2024.
- Across the five-year window, Receivables - Net tumbled 97.96% in 2023 and surged 9856.0% in 2024, its largest moves.
- Year by year, Receivables - Net stood at $16.8 million in 2022, then slipped by 11.31% to $14.9 million in 2023, then declined by 20.78% to $11.8 million in 2024, then soared by 225.03% to $38.4 million in 2025, then dropped by 26.66% to $28.1 million in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $28.1 million in Q1 2026, $38.4 million in Q4 2025, and $17.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.14 Mn |
| Mar 31, 2026 | 28.14 Mn |
| Dec 31, 2025 | 38.37 Mn |
| Dec 31, 2025 | 38.37 Mn |
| Sep 30, 2025 | 17.38 Mn |
| Sep 30, 2025 | 17.38 Mn |
| Jun 30, 2025 | 27.14 Mn |
| Jun 30, 2025 | 27.14 Mn |
| Mar 31, 2025 | 28.90 Mn |
| Mar 31, 2025 | 28.90 Mn |
| Dec 31, 2024 | 11.80 Mn |
| Dec 31, 2024 | 11.80 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Jun 30, 2024 | 23.35 Mn |
| Jun 30, 2024 | 23.35 Mn |
| Mar 31, 2024 | 19.91 Mn |
| Mar 31, 2024 | 19.91 Mn |
| Dec 31, 2023 | 14.90 Mn |
| Dec 31, 2023 | 14.90 Mn |